The Retinoblastoma Gene and its Significance

References

• Vogel F. Genetics of retinoblastoma. Hum Genet 1979; 52: 1–54.
   PubMed Web of Science ®Google Scholar
• Draper GJ, Sanders BM, Brownbill PA, Hawkins MM. Patterns of risk of hereditary retinoblastoma and applica-tions to genetic counselling. Br J Cancer 1992; 66: 211–9.
   PubMedGoogle Scholar
• Knudson AG. Mutation and cancer: statistical study of retinoblastoma Proc Nat! Acad Sci USA 1971; 68: 820–3.
   PubMedGoogle Scholar
• Comings DE. A general theory of carcinogenesis. Proc Nat/ Aced Sci USA 1973; 70: 3324–8.
   PubMed Web of Science ®Google Scholar
• Knudson AG, Strong LC. Mutation and cancer: a model for Wilms' tumor of the kidney. J Nat! Cancer lnst 1972; 48:313–33.
   PubMed Web of Science ®Google Scholar
• Knudson AG, Strong LC. Mutation and cancer: neuro-blastoma and pheochromocytoma. Am J Hum Genet 1972; 24:514–24.
   PubMed Web of Science ®Google Scholar
• Vogeistein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525–32.
   PubMedGoogle Scholar
• Jackson CE, Block MA, Greenawald KA, Tashjian AH. The two-mutational-event theory in medullary thyroid cancer. Am J Hum Genet 1979; 31: 704–10.
   PubMed Web of Science ®Google Scholar
• Mooigavkar SH, Day NE, Stevens RG. Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J Nat! Cancer Inst 1980; 65: 559–69.
   PubMedGoogle Scholar
• Lele KP, Penrose LS, Stallard HB. Chromosome deletion in a case of retinoblastoma Ann Hum Genet 1963; 27: 171–4.
   PubMed Web of Science ®Google Scholar
• Orye E, Delbeke MJ, Vandenabeeie B. Retinoblastoma and long arm deletion at chromosome 13: attempts to define the deleted segment. Clin Genet 1974; 5: 457–64.
   PubMedGoogle Scholar
• Francke U. Retinoblastoma and chromosome 13. Cyto-genet Cell Genet 1976; 16:131–4.
   PubMedGoogle Scholar
• Balaban-Mallenbaum G, Gilbert F, Nichols WW, Hill R, Shield J, Meadows AT. A deleted chromosome no. 13 in human retinoblastoma cells: relevance to tumorigenesis. Cytogenet Cell Genet 1981; 3: 243–50.
   Google Scholar
• Balaban G, Gilbert F, Nichols WW, Meadows AT. Abnor-malities of chromosome 13 in retinoblastoma in indivi-duals with normal constitutional karyotypes. Cancer Genet Cytogenet 1982; 6:213–21.
   PubMed Web of Science ®Google Scholar
• Strong LC, Riccardi VM, Ferrell RE, Sparkes RS. Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science 1981; 213:1501–3.
   PubMed Web of Science ®Google Scholar
• Sparkes RS, Sparkes MC, Wilson MG, et al. Regional assignment of genes for human esterase D and retino-blastoma to chromosome band 13q14. Science 1980; 208:1042–4.
   PubMed Web of Science ®Google Scholar
• Sparkes RS, Murphree AL, Lingua RW, et al. Gene for hereditary retinoblastoma assigned to human chromo-some 13 by linkage to esterase D. Science 1983; 219: 971–3.
   PubMed Web of Science ®Google Scholar
• Sparkes RS, Sparkes MC, Kalina RE, Pagon RA, Salk DJ, Disteche CM. Separation of retinoblastoma and esterase D loci in a patient with sporadic retinoblastoma and del(13)(q14.1q22.3). Hum Genet 1984; 68:258–9.
   PubMedGoogle Scholar
• Sparkes RS, Sparkes MC. Esterase D studies in human retinoblastoma. lsozymes. Curr Top Bic' Med Res 1983; 11: 173–82.
   PubMedGoogle Scholar
• Cavenee WK, Dryja TP, Phillips RA, et al. Expression of recessive alleles by chromosomal mechanisms in retino-blastoma. Nature 1983; 305:779–84.
   PubMed Web of Science ®Google Scholar
• Cavenee WK, Hansen MF, Nordenskjoid M, et al. Genetic origin of mutations predisposing to retino-blastoma. Science 1985; 228: 501–3.
   PubMed Web of Science ®Google Scholar
• Laiande M, Donlon T, Petersen RA, Liberfarb R, Manter S, Latt SA. Molecular detection and differentiation of deletions in band 13q14 in human retinoblastoma. Cancer Genet Cytogenet 1986; 23:151–7.
   PubMedGoogle Scholar
• Dryja TP, Rapaport JM, Joyce JM, Petersen RA. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Nat! Acad Sci USA 1986; 83:7391–4.
   PubMed Web of Science ®Google Scholar
• Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–6.
   PubMed Web of Science ®Google Scholar
• Fung YK, Murphree AL, T'Ang A, Olen J, Hinrichs SH, Benedict WF. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 236: 1657–61.
   PubMed Web of Science ®Google Scholar
• Lee WH, Bookstein R, Hong F, Young Li, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987; 235: 1394–99.
   PubMed Web of Science ®Google Scholar
• McGee TL, Yandell DW, Dryja TP. Structure and partial genomic sequence of the human retinoblastoma suscep-tibility gene. Gene 1989; 80: 119–28.
   PubMed Web of Science ®Google Scholar
• Destree OH, Lam KT, Peterson-Maduro LJ, et al. Struc-ture and expression of the Xenopus retinoblastoma gene. Dev Biol 1992; 153:141–9.
   PubMed Web of Science ®Google Scholar
• Bernards R, Schackleford GM, Gerber MR, et al. Struc-ture and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc Nat! Acad Sc! USA 1989; 86: 6474–8.
   PubMed Web of Science ®Google Scholar
• Roy NK, Baliesteros A, Gado SJ. Cloning and sequence of the rat retinoblastoma (Rb) gene cDNA. Nucleic Acids Res 1993; 21:170.
   PubMedGoogle Scholar
• Lee WH, Shew JY, Hong FD, et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329: 642–5.
   PubMed Web of Science ®Google Scholar
• DeCaprio JA, Lundlow JW, Lynch D, et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element Cell 1989; 58: 1085–95.
   Google Scholar
• De Capri° JA, Furukawa Y, Ajchenbaum F, Griffin JD, Livingston DM. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Nat! Acad Sci USA 1992; 89: 1795–8.
   PubMedGoogle Scholar
• Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097–1105.
   PubMed Web of Science ®Google Scholar
• Chen PL, Scully P, Shew JY, Wang JY, Lee WH. Phos-phorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58:1193–98.
   PubMed Web of Science ®Google Scholar
• Mittnacht S, Hinds PW, Dowdy SF, Weinberg RA. Modulation of retinoblastoma protein activity during the cell cycle. Cold Spring Harb Symp Quant Biol 1991; 56: 197–209.
   PubMedGoogle Scholar
• Cobrinlk D, Dowdy SF, Hinds PW, Mittnacht S, Wein-berg RA. The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 1992; 17:312–5.
   PubMedGoogle Scholar
• DeCaprio JA, Ludlow JW, Figge J, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–83.
   PubMed Web of Science ®Google Scholar
• Whyte P, Buchkovich KJ, Horowitz JM, et at. Associa-tion between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124–9.
   PubMed Web of Science ®Google Scholar
• Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934–7.
   PubMed Web of Science ®Google Scholar
• Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Nat/ Acad Sc/USA 1993; 90: 5455–9.
   PubMed Web of Science ®Google Scholar
• Jiang WO, Szekely L, Wendel-Hansen V, Ringertz N, Klein G, Rosen A. Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp Cell Res 1991; 197:314–8.
   PubMedGoogle Scholar
• Chellappan SP, Hlebert S, Mundryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the FIB protein. Cell 1991; 65: 1053–61.
   PubMed Web of Science ®Google Scholar
• Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258:424–9.
   PubMed Web of Science ®Google Scholar
• Fattaey AR, Helin K, Dembskl MS, et at. Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene 1993; 8: 3149–56.
   PubMed Web of Science ®Google Scholar
• Chittenden T, Livingston DM, Kaelin W Jr. RB associates with an E2F-like, sequence-specific DNA-binding protein. Cold Spring Harb Symp Quant Biol 1991; 56:187–95.
   PubMedGoogle Scholar
• Hamel PA, Phillips RA, Muncaster M, Gallie BL. Specu-lations on the roles of RB1 in tissue-specific differentia-tion, tumor initiation, and tumor progression. FASEB J 1993; 7: 846–54.
   PubMed Web of Science ®Google Scholar
• Richon VM, Rif kind RA, Marks PA. Expression and phos-phorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ 1992; 3:413–20.
   PubMedGoogle Scholar
• Slack RS, Hamel PA, Biadon TS, Gill RM, McBurney MW. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene 1993; 8:1585–91.
   PubMedGoogle Scholar
• Strohmeyer T, Relssmann P, Cordon-Cardo C, Hart-mann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Nati Acad Sc! USA 1991; 88: 6662–6.
   PubMed Web of Science ®Google Scholar
• Szekely L, Jiang WO, Bulic-Jakus F, et al. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ 1992; 3: 149–56.
   PubMedGoogle Scholar
• Yen A, Chandler S. Inducers of leukemic cell differentia-tion cause down-regulation of RB gene expression. Proc Soc Exp Biol Med 1992; 199: 291–7.
   PubMedGoogle Scholar
• Ewen ME, Xing YG, Lawrence JB, Livingston DM. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 1991; 66: 1155–64.
   PubMed Web of Science ®Google Scholar
• Bautista C, Edwards GM, Defeo-Jones D, Jones RE . Antibodies specific for the human retino-blastoma protein identify a family of related polypeptides. Mot Cell Biol 1991; 11: 5792–9.
   Google Scholar
• Mayol X, Grana W, Baldi A, Sang N, Hu 0, Giordano A. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 1993; 8: 2561–6.
   PubMed Web of Science ®Google Scholar
• Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long term survivors of retinoblastoma. J Nat! Cancer Inst 1993; 85: 1121–8.
   PubMed Web of Science ®Google Scholar
• Kitchin FD, Ellsworth RM. Pleiotropic effects of the gene for retinoblastoma. J Med Genet 1974; 11: 244–6.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Ronner HJ, Ellsworth RM. Second tumors in nonirradiated bilateral retinoblastoma. Am J Ophthalmo11979; 87: 624–7.
   Google Scholar
• Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology 1984; 91: 1351–5.
   Google Scholar
• Hansen MF, Koufos A, Gallie BL, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Nat! Acad Sci USA 1985; 82: 6216–20.
   PubMed Web of Science ®Google Scholar
• Toguchida J, ishizaki K, Sasaki MS, et al. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 1988; 48: 3939–43.
   PubMed Web of Science ®Google Scholar
• Wunder JS, Czitron AA, Kande! R, Andrulis IL. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Nati Cancer Inst 1991;83: 194–200.
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR, Beckett M, Diamond A. Some retino-blastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. Proc Nati Acad Sc! USA 1988; 85:2106–9.
   PubMed Web of Science ®Google Scholar
• Shew JY, Ling N, Yang XM, Fodstad 0, Lee WH. Anti-bodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp1 1 ORB) in osteosarcomas and synovial sarcomas. Oncogene Res 1989; 4:205–14.
   PubMedGoogle Scholar
• Araki N, Uchida A, Kimura T, et al. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors. Clin Orthop 1991; 270: 271–1.
   PubMedGoogle Scholar
• Scholz RB, Kabisch H, Weber B, Roser K, Dolling G, Winkler K. Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Once! 1992; 9: 125–37.
   PubMed Web of Science ®Google Scholar
• Ozaki T, Ikeda S, Kawal A, Inoue II, Oda T. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors. Cell Mol Biol 1993; 39: 235–42.
   PubMed Web of Science ®Google Scholar
• Dryja TP, Rapaport JM, Epstein J, et al. Chromosome 13 homozygosity in osteosarcoma without retinoblastoma. Am J Hum Genet 1986; 38: 59–66.
   PubMed Web of Science ®Google Scholar
• Canoe WG, Brennan MF, Dudas ME, Huang C-M, Cordon-Cardo C. Altered expression of the retino-blastoma gene product in human sarcomas. N Eng! J Med 1990; 323:1457–62.
   PubMedGoogle Scholar
• Reissmann PT, Simon MA, Lee WH, Slamon DJ. Studies of the retinoblastoma gene in human sarcomas. Onco-gene 1989; 4: 839–43.
   Google Scholar
• Scheffer H, Kruize YC, Osinga J, et al. Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma. Cancer Genet Cytogenet 1991; 53: 45–55.
   PubMedGoogle Scholar
• Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988; 241: 218–221.
   PubMed Web of Science ®Google Scholar
• TAng A, Variey JM, Chakraborty S, Murphree AL, Fung YK. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988; 242: 263–6.
   PubMed Web of Science ®Google Scholar
• Variey JM, Armour J, Swallow JE, et al. The retina-blastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene 1989; 4: 725–9.
   PubMedGoogle Scholar
• Harbour JW, Lai SL, Whang PJ, Gazdar AF, Minna JD, Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241: 353–7.
   PubMed Web of Science ®Google Scholar
• Reissmann PT, Koga H, Takahashi R, et al. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 1993; 8: 1913–9.
   PubMed Web of Science ®Google Scholar
• Xu HJ, Hu SX, Cagle PT, Moore GE, Benedict WF. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 1991; 51: 2735–9.
   PubMed Web of Science ®Google Scholar
• Horowitz JM, Yandell DW, Park SH, et al. Point mutational inactivation of the retinoblastoma antionco-gene. Science 1989; 243: 937–40.
   PubMed Web of Science ®Google Scholar
• Goodrich DW, Chen Y, Scully P, Lee WH. Expression of the retinoblastoma gene product in bladder carcinoma cells associated with a low frequency of tumor formation. Cancer Res 1992; 52: 1968–73.
   PubMedGoogle Scholar
• Takahashi R, Hashimoto T, Xu HJ, et al. The retino-blastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Nat! Acad Sc/USA 1991; 88: 5257–61.
   PubMed Web of Science ®Google Scholar
• Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 1993; 53: 781–4.
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, Wartinger D, Petrylak D, et al. Altered expression of the retinoblastoma gene product: prog-nostic indicator in bladder cancer. J Nat! Cancer Inst 1992; 84: 1251–6.
   PubMed Web of Science ®Google Scholar
• Logothetis CJ, Xu HJ, Ro JY, et al. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Nat! Cancer Inst 1992; 84: 1256–61.
   PubMed Web of Science ®Google Scholar
• James CD, Carlbom E, Dumanski JP, et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988; 48:5546–51.
   PubMed Web of Science ®Google Scholar
• Chen YC, Chen PJ, Yeh SH, et al. Deletion of the human retinoblastoma gene in primary leukemias. Blood 1990; 76:2060–4.
   PubMed Web of Science ®Google Scholar
• Hansen MF, Morgan R, Sandberg AA, Cavenee WK. Structural alterations at the putative retinoblastoma locus in some human leukemias and preleukemia. Cancer Genet Cytogenet 1990; 49: 15–23.
   PubMedGoogle Scholar
• Hillion J, Larsen CJ, Berger R. Hemizygous deletion of the 3' end of the RB1 gene in a case of Philadelphia positive-acute lymphoblastic leukemia Cancer Genet Cytogenet 1991; 54: 197–203.
   Google Scholar
• Kay NE, Suen R, Ranheim E, Peterson LC. Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone. Br J Haematol 1993; 84: 257–64.
   PubMed Web of Science ®Google Scholar
• Sen S, Takahashi R, Rani S, Freireich EJ, Stass SA. Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines. Leuk Res 1993; 17: 639–47.
   PubMed Web of Science ®Google Scholar
• Tang JL, Yeh SH, Chen PJ, Lin MT, Tien HF, Chen YC. Inactivation of the retinoblastoma gene in acute myelo-genous leukaemia Br J Haematol 1992; 82: 502–7.
   Google Scholar
• Weide R, Parviz B, Pfluger KH, Havemann K. Altered expression of the human retinoblastoma gene in mono-zygotic leukaemias. Br J Haematol 1993; 83: 428–32.
   PubMed Web of Science ®Google Scholar
• Lee NK, Ye YW, Chen J, LI X, Weber PG, Nisen PD. p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1993; 199: 1125–31.
   Google Scholar
• Crook T, Wrede D, Tidy J, Scholefleid J, Crawford L, Vousden KH. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus. Oncogene 1991; 6:1251–7.
   PubMedGoogle Scholar
• Boynton RF, Huang Y, Blount PL, et al. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res 1991; 51: 5766–9.
   Google Scholar
• Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Res 1991; 51:6393–6.
   PubMed Web of Science ®Google Scholar
• De Chiara A, T'Ang A, Triche TJ. Expression of the retinoblastoma susceptibility gene in childhood rhabdo-myosarcomas. J Nat! Cancer Inst 1993; 85: 152–7.
   PubMedGoogle Scholar
• Li SB, Schwartz PE, Lee WH, Yang FTL. Allele loss at the retinoblastoma locus in human ovarian cancer. J Nat! Cancer Inst 1991; 83: 637–40.
   PubMedGoogle Scholar
• Bookstein R, Lee WH. Molecular genetics of the retino-blastoma suppressor gene. Grit Rev Oncog 1991; 2: 211–27.
   PubMedGoogle Scholar
• Sarkar FH, Sakr W, LI YW, Macoska J, Ball DE, Criss-man JD. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate 1992; 21: 145–52.
   PubMed Web of Science ®Google Scholar
• Steeg PS. Suppressor genes in breast cancer: an over-view. Cancer Treat Abs 1992; 61: 45–57.
   PubMedGoogle Scholar
• Fung YK and TAng A. The role of the retinoblastoma gene in breast cancer development. Cancer Treat Res 1992; 61:59–68.
   PubMedGoogle Scholar
• Borg A, Zhang CiX, Alm P, Olsson H, Seliberg G. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 1992; 52: 2991–4.
   PubMed Web of Science ®Google Scholar
• Wang NP, To H, Lee WH, Lee EY. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells. Oncogene 1993; 8: 279–88.
   PubMed Web of Science ®Google Scholar
• Birch JM. Epidemiology of sarcomas. Curr Opin Once 1990; 2: 462–6.
   PubMedGoogle Scholar
• Yandell DW, Dryja TP. Detection of DNA polymorphisms by enzymatic amplification and direct genomic sequenc-ing. Am J Hum Genet 1989; 45: 547–55.
   PubMed Web of Science ®Google Scholar
• Yandell DW, Campbell TA, Dayton SH, et al. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med 1989; 321:1689–95.
   PubMed Web of Science ®Google Scholar
• Onadim Z, Cowell JK. Application of PCR amplification of DNA from paraffin embedded tissue sections to linkage analysis in familial retinoblastoma. J Med Genet 1991; 28: 312–6.
   PubMedGoogle Scholar
• Bookstein R, Show JY, Chen PL, Scully P, Lee WH. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990; 247:712–5.
   PubMed Web of Science ®Google Scholar
• Chen PL, Chen Y, Shan B, Booksteln R, Lee WH. Stability of retinoblastoma gene expression determines the tumourigenicity of reconstituted retinoblastoma cells. Cell Growth Differ 1992; 3: 119–25.
   PubMedGoogle Scholar
• Fung YK, TAng A, Murphree AL, et al. The Rb gene suppresses the growth of normal cells. Oncogene 1993; 8: 2659–72.
   PubMed Web of Science ®Google Scholar
• Huang HJ, Yee JK, Shew JY, et at. Suppression of the neopiastic phenotype by replacement of the RB gene in human cancer cells. Science 1988; 242:1563–6.
   PubMed Web of Science ®Google Scholar
• Madreperla SA, Whittum HJA, Prendergast RA, Chen PL, Lee WH. Intraocular tumor suppression of retino-blastoma gene-reconstituted retinoblastoma cells. Cancer Res 1991; 51:6381–4.
   PubMed Web of Science ®Google Scholar
• Ookawa K, Shisekl M, Takahashi R, Yoshida Y, Terada M, Yokota J. Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations. Oncogene 1993; 8:2175–81.
   PubMedGoogle Scholar
• Lee EY, Chang CV, Hu N, et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992; 359: 288–94.
   PubMed Web of Science ®Google Scholar
• Jacks T, Fazell A, Schmitt EM, Bronson RI, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992; 359: 295–300.
   PubMed Web of Science ®Google Scholar